Similarly, in patients with breast cancer, the inhibition of GPX3 expression through promoter hypermethylation has been associated with the proliferation, migration and invasion of tumor cells
An experiment with hepatic stellate cells, which are key in the development of liver fibrosis, revealed that EGCG can regulate the growth and structure of these cells, such that EGCG may turn out to be a therapeutic agent for liver fibrosis (Higashi, Kohjima 2005)
Furthermore, when combined with GLP-1, GIP could relieve common gastrointestinal-related adverse effects in GLP-1 receptor agonist such as nausea, vomiting and diarrhea
This is a disease where fat builds up in the liver, leading to scarring and cirrhosis if left untreated
First appearance in Japan